Rohit Gupta

Rohit Gupta is a biobanking and precision medicine leader who previously oversaw centers at Stanford and UCSF, serving as the leading scientific and strategic force behind ChronicleBio, which officially launched in August 2025. Founded alongside tech executive Fidji Simo and investor Rishi Reddy, ChronicleBio is creating a scalable, ethically driven data ecosystem integrating clinical, molecular, biospecimen, and patient-reported insights to drive biomarker discovery, patient stratification, and precision therapeutic development. The company addresses a critical gap in biomedical research: complex chronic conditions impact nearly 300 million people worldwide but remain woefully understudied.

Gupta's mission is deeply personal: Gupta's family suffers from neuroimmune disorders. He completed an Advanced Program Management certificate at Stanford University (2013–2014). In April 2025, ChronicleBio launched a collaboration with Solve M.E., the Brain Inflammation Collaborative, and other organizations to advance research on ME/CFS, Long COVID, and other chronic conditions.

Career history

• Metrodora Institute – Chief Executive Officer
• Fight Cancer Global
• Journal of Biopreservation & Biobanking

What Gupta could bring to ChronicleBio: Drawing on decades of biobanking infrastructure expertise from Stanford and UCSF, combined with his leadership at precision medicine organizations and deep personal commitment to solving neuroimmune disorders, Gupta is positioned to translate academic biobank models into a scalable, AI-ready platform that bridges research silos, a capability rarely found in biotech founders and critical for accelerating therapeutics in historically under-resourced disease areas.

This is an automatically generated Light profile created by Executive Moves editorial systems from verified public announcements. Information is kept deliberately concise until the page is claimed and enriched.